Healthcare

Three ASX 200 Stocks Propel Market Gains This Week

Highlights:,Neuren Pharmaceuticals Leads the Week: Neuren Pharmaceuticals (ASX:NEU) saw a 33.8% increase in its share price following positive updates...

ResMed (ASX: RMD) Shares Evaluated for Future Growth Prospects

Highlights:,ResMed's Strong Financial Performance: A reported 13.6% compound annual growth rate (CAGR) in revenue over the last three years and a 29.1...

Neuren Pharmaceuticals Shares Surge on Strong Sales

Highlights,Neuren,Pharmaceuticals sees a 13.2% share price increase.,The company reports US sales of its,Daybue,drug surpassing $250 million in the fi...

Imugene (ASX:IMU) Expands Azer-cel CAR T-cell Lymphoma Trial in Aust...

Highlights,Imugene,launches Australian site for,azer,-cel CAR T-cell therapy trial,.,Sydney’s Royal Prince Alfred Hospital to lead DLBCL patient recru...

Mayne Pharma (ASX: MYX) Gains Momentum Amid Strategic Interest Explo...

Highlights,Mayne Pharma shares surge following confirmation of strategic interest.,Jefferies Australia exploring prospective buyers for the company.,M...

Sigma Healthcare Has Led the Top Gainers as the S&P/ASX 200 Sees a M...

Highlights:,Sigma Healthcare (ASX) Surges Following Merger Approval,Neuren Pharmaceuticals (ASX) Gains Amid Growing Optimism in Neurological Treatment...

Neuren’s ‘Willy Wonka’ Voucher Has Been Revalued at US$50 Million

Highlights:,Neuren Pharmaceuticals (ASX) benefits from a significant windfall through the sale of a US FDA Priority Review Voucher (PRV).,Sigma Health...

ACCC Approval of Sigma-Chemist Warehouse Merger Sparks Market Intere...

Highlights,ACCC grants approval for Sigma Healthcare and Chemist Warehouse merger.,Court-enforceable undertaking ensures fair market competition.,Chem...

Amplia Therapeutics Successfully Raises $13 Million via Share Allotm...

Highlights:,Amplia Therapeutics Ltd. successfully raised $13 million through an institutional placement.,Over 67 million shares were allotted at a pri...

Sigma (ASX:SIG) Shares Rise 30% After Chemist Warehouse Merger Gets...

Highlights:,Sigma Healthcare's share price surged 31% following the approval of its merger with Chemist Warehouse.,The Australian Competition & Consum...

Sigma Healthcare Moves Forward with Merger as ACCC Approves Deal wit...

Highlights,The Australian Competition and Consumer Commission (ACCC) approves Sigma Healthcare’s merger with Chemist Warehouse Group (CWG), with condi...

Neuren’s FY2024: Revenue Surge from Tax Credits & Drug Partnerships

Highlights,Neuren,forecasts FY2024 income in the range of $216 million to $218 million.,Expected $17 million tax credit due to recognized New Zealand...

Sigma Healthcare Secures ACCC Approval for Chemist Warehouse Merger

Highlights,ACCC grants approval for Sigma Healthcare’s merger with Chemist Warehouse.,Sigma commits to competitive practices and pharmacy service obli...

Key ASX Penny Stocks for November 2024 Identified

Highlights:,The ASX200 is showing signs of upward momentum, influenced by positive movements on Wall Street and global events such as China’s National...

Alterity’s 'Iron Overload in Brain' Thesis Endorsed by Prominent Pub...

Highlights:,Alterity Therapeutics (ASX) receives peer-reviewed recognition for its neurological drug candidate ATH434 in,Metallomics,.,Respiri (ASX) p...

Neuren Pharmaceuticals Shares Surge 6% on $150 Million PRV Sale

Highlights,Neuren Pharmaceuticals' stock rises 6%, marking its biggest intraday gain since September 27.,The company will receive one-third of the $15...

Insider Confidence Rises as Mesoblast Executives Acquire Additional...

Highlights,Mesoblast insiders increase holdings, signaling confidence.,Gregory George makes largest purchase, valued at AU$15 million.,Insider ownersh...

Tryptamine Therapeutics Advances Clinical Strategy with Board Reshuf...

Highlights,Tryptamine Therapeutics acknowledges Peter Molloy's contributions amid board transition.,Strategic placement to support TRP-8803 trial adva...

CardieX Limited (ASX:CDX): Exploring the Journey to Financial Succes...

Highlights,CardieX Limited is anticipated to achieve profitability by 2026.,Forecasts suggest a strong annual growth rate of 91%.,The company holds a...

Freedom Care Group Faces Potential NDIS Ban Amid Program Audit

Highlights,Freedom Care Group faces potential license revocation by NDIS.,Cash flow impact as NDIS program contributes significantly to revenue.,Revie...